Thank you to our speakers, sponsors, and delegates who joined us in January for the summit! If you are interested in the 2025 event, please get in touch at firstname.lastname@example.org.
Delivering Clinical Proof of Concept Through Advanced Analytics & Enhanced Product Characterisation to Elucidate Mechanism of Action & Achieve Regulatory Approval in Europe
30th January - 1st February, 2024 | Barcelona, Spain
Welcome to the 8th Microbiome Movement - Drug Development Summit Europe
With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe’s leading microbiome organisations were paving the way for drug development!
At the 8th Microbiome Movement - Drug Development Summit Europe where we covered the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators united in Barcelona for the flagship meeting for European microbiome-based therapeutic developers.
We brought together microbiome trailblazers across industry, academia and investors to share their insights across autoimmune disorders, oncology, lung disease, hepatic disease, women’s health and more! With new interactive sessions such as a reverse pitch opportunity, technology showcase, poster session and guided networking. This unmissable event provided the opportunity to transform your drug development pipelines and meet like-minded individuals to help you along the way.
2024's World-Class Speaker Faculty Included
Chief Executive Officer
Freya Biosciences ApS
Founder & Chief Scientific Officer
In 2024 We Covered:
Unearth more dedicated sessions across oncology research to reveal further MoA understandings from advanced melanoma, NSC lung cancer, breast cancer and epithelial cancers with Microbiotica, Pulmobiotics, Gnubiotics and Recolony
Engage in our exclusive reverse pitch opportunity with our investor panel to find out exactly what it takes to secure continued investment and uncover your competitive advantage for approaching investors
Gain clarity on European regulatory guidance for approval of therapies with late-stage microbiome leaders sharing exactly what interactions they’ve had EMA and FDA. We dig into novel regulatory questions around engineered microbes and the use of artificial intelligence
"In a field with many conferences of varying quality, the Microbiome Drug Development Summit consistently delivers substantive and compelling conversations and a collaborative vibe"
"We need to combine our efforts to accelerate the knowledge and translation into the clinic, and the Microbiome Movement is offering exactly what we are needing."
Institute Gustave Roussy
Our 2024 Partners